Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Interleukin-2 for Hepatitis Vaccination in HIV
NCT00451984Phase 3Unknown
- Sponsor
- Aalborg University Hospital
- Start
- Mar 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aldesleukin in hepatitis A (HAV) and hepatitis B (HBV) (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Antibody response to hepatitis A and hepatitis B. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00451984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451984.